Evidence map›Paper›PMID 38815701›Full record

ArticleInternational journal of antimicrobial agents2024

Dynamic evolution of Achromobacter xylosoxydans in a patient with leukemia receiving antibiotic treatment.

German Matias Traglia, Nicholas Furtado, Jenny Escalante, Marisa Almuzara, Roxana Marisa Cittadini, Marisel R Tuttobene, Tomás Subils, Carolina Dominguez Maldonado, Veronica Viard, Soledad Estela Gonzalez and 5 more

Abstract readLetterCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of antimicrobial agents, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

German Matias TragliaUnidad de Genómica y Bioinformática, Departamento de Ciencias Biológicas, CENUR Litoral Norte, Universidad de la República, Salto, Uruguay.
Nicholas FurtadoCenter for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, California, USA.
Jenny EscalanteCenter for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, California, USA.
Marisa AlmuzaraUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Bioquímica Clínica, Cátedra de Microbiología Clínica, Buenos Aires, Argentina.
Roxana Marisa CittadiniLaboratorio de Microbiologia, Sanatorio Mater Dei CABA, Ciudad Autonoma de Buenos Aires, Argentina.
Marisel R TuttobeneInstituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Rosario, Argentina.
Tomás SubilsInstituto de Procesos Biotecnológicos y Químicos de Rosario (IPROBYQ, CONICET-UNR), Rosario, Argentina.
Carolina Dominguez MaldonadoCenter for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, California, USA.
Veronica ViardServicio de Pediatria, Sanatorio Mater Dei CABA, Ciudad Autonoma de Buenos Aires, Argentina.
Soledad Estela GonzalezServicio Infectologia Pediatrica, Sanatorio Mater Dei CABA, Ciudad Autonoma de Buenos Aires, Argentina.
Maria Ines SormaniServicio Infectologia Pediatrica, Sanatorio Mater Dei CABA, Ciudad Autonoma de Buenos Aires, Argentina.
Marcelo E TolmaskyCenter for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, California, USA.
Carlos VayUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Bioquímica Clínica, Cátedra de Microbiología Clínica, Buenos Aires, Argentina; Laboratorio de Microbiologia, Sanatorio Mater Dei CABA, Ciudad Autonoma de Buenos Aires, Argentina.
Gauri RaoUniversity of Southern California, Los Angeles, California, USA.
Maria Soledad RamirezCenter for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, California, USA. Electronic address: msramirez@fullerton.edu.

Funding

Minority Health and Health Disparities International Research Training ProgramT37MD001368 · NIMHD · CALIFORNIA STATE UNIVERSITY FULLERTON · PI TOLMASKY, MARCELO E · 2005 to 2024
$3.9M
DEALING WITH ANTIBIOTIC RESISTANCE--ANTISENSE TECHNOLOGYR15AI047115 · NIAID · CALIFORNIA STATE UNIVERSITY FULLERTON · PI TOLMASKY, MARCELO E · 2000 to 2022
$1.8M
U-RISE at Cal State FullertonT34GM149493 · NIGMS · CALIFORNIA STATE UNIVERSITY FULLERTON · PI MATH P CUAJUNGCO · 2023 to 2026
$1.3M
Identifying host human products responsible for natural transformation of resistance traits in Acinetobacter sppSC3GM125556 · NIGMS · CALIFORNIA STATE UNIVERSITY FULLERTON · PI RAMIREZ, MARIA SOLEDAD · 2018 to 2025
$851k
NIAID NIH HHS R15 AI047115NIGMS NIH HHS SC3 GM125556NIGMS NIH HHS T34 GM149493NIMHD NIH HHS T37 MD001368
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Achromobacter denitrificansAnti-Bacterial AgentsGram-Negative Bacterial InfectionsEvolution, MolecularHumansLeukemiaMicrobial Sensitivity TestsAnti-Bacterial Agents

Identifiers

PMID38815701
PMCPMC11426103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.